Alnylam Pharmaceuticals Inc <ALNY.O>: Oppenheimer cuts target price to $350 from $500
ALNY•Related News
Hesai shareholders vote on raising 2026 Sharpa supply deal cap to RMB 300 million
HSAI•
U.S. Research Roundup- Apple, Amazon, Mastercard
AAPL•
ExxonMobil misses second quarter profit estimates despite hitting four-year high
XOM•
Enova report shows 61% of small businesses use AI in Q2 2026
ENVA•
Zhibao to replace CEO, CFO as investors nominate new board slate after PIPE closing
ZBAO•